Multipronged Infection Control Strategy to Achieve Zero Nosocomial Coronavirus Disease 2019 (COVID-19) Cases Among Hong Kong Healthcare Workers in the First 300 Days of the Pandemic
Overview
Infectious Diseases
Nursing
Public Health
Authors
Affiliations
Background: Nosocomial outbreaks leading to healthcare worker (HCW) infection and death have been increasingly reported during the coronavirus disease 2019 (COVID-19) pandemic.
Objective: We implemented a strategy to reduce nosocomial acquisition.
Methods: We summarized our experience in implementing a multipronged infection control strategy in the first 300 days (December 31, 2019, to October 25, 2020) of the COVID-19 pandemic under the governance of Hospital Authority in Hong Kong.
Results: Of 5,296 COVID-19 patients, 4,808 (90.8%) were diagnosed in the first pandemic wave (142 cases), second wave (896 cases), and third wave (3,770 cases) in Hong Kong. With the exception of 1 patient who died before admission, all COVID-19 patients were admitted to the public healthcare system for a total of 78,834 COVID-19 patient days. The median length of stay was 13 days (range, 1-128). Of 81,955 HCWs, 38 HCWs (0.05%; 2 doctors and 11 nurses and 25 nonprofessional staff) acquired COVID-19. With the exception of 5 of 38 HCWs (13.2%) infected by HCW-to-HCW transmission in the nonclinical settings, no HCW had documented transmission from COVID-19 patients in the hospitals. The incidence of COVID-19 among HCWs was significantly lower than that of our general population (0.46 per 1,000 HCWs vs 0.71 per 1,000 population; P = .008). The incidence of COVID-19 among professional staff was significantly lower than that of nonprofessional staff (0.30 vs 0.66 per 1,000 full-time equivalent; P = .022).
Conclusions: A hospital-based approach spared our healthcare service from being overloaded. With our multipronged infection control strategy, no nosocomial COVID-19 in was identified among HCWs in the first 300 days of the COVID-19 pandemic in Hong Kong.
Ma E, Wong S, Cheng V, Chen H, Wu P Microorganisms. 2025; 12(12.
PMID: 39770837 PMC: 11678779. DOI: 10.3390/microorganisms12122635.
Almeida F, Correia S, Leal C, Guedes M, Duro R, Andrade P J Clin Med. 2024; 13(17).
PMID: 39274464 PMC: 11396589. DOI: 10.3390/jcm13175251.
Antibiotic use in hospitalized patients with COVID-19: a population-based study in Hong Kong.
Blais J, Zhang W, Lin Y, Chui C, Cheng V, Cowling B Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e205.
PMID: 38028893 PMC: 10654948. DOI: 10.1017/ash.2023.485.
Xia T, Shi S, Yang J, Sun D, Suo J, Kuang H Infect Prev Pract. 2023; 5(4):100309.
PMID: 37744681 PMC: 10514403. DOI: 10.1016/j.infpip.2023.100309.
Law S, Au D, Chow W, Poon C, Chow K, Zhao Z Evid Based Complement Alternat Med. 2023; 2023:5637720.
PMID: 37680699 PMC: 10482558. DOI: 10.1155/2023/5637720.